If you would like to submit a blog post for consideration, please email email@example.com
If you have an interest in dermoscopy and skin cancer medicine, don’t miss the International Dermoscopy Society’s 5th World Congress of Dermoscopy, to be held in Thessaloniki, Greece from 14 to 16 June 2018.
The Congress will bring together passionate dermoscopists from around the globe, from novice researchers to experienced clinicians. It offers a great opportunity for medical professionals interested in skin cancer to learn about the latest research in dermoscopy from inspirational thought leaders in the field. Continue reading “HealthCert Recommends: The IDS 5th World Congress of Dermoscopy”
In our last skin cancer update video for 2017, Associate Professor Giuseppe Argenziano discusses the process of monitoring patients with multiple nevi, and how melanoma comes to be diagnosed in these patients.
Around 10 percent of melanomas diagnosed today have been monitored over time in patients with multiple nevi. Practitioners often ask whether a side-by-side comparison is needed in patients with multiple nevi in order to assess changes, or whether the lesions develop to fit specific melanoma criteria over time and can therefore be diagnosed without a side-by-side comparison. Continue reading “Skin Cancer Update with A/Prof Giuseppe Argenziano [December]”
Do we need pigment to develop melanoma? This question was discussed at the 2017 European Academy of Dermatology and Venereology by Professor David E Fisher, who presented interesting findings in melanoma research.
Research shows that black mice with BRAF mutations that activate the RAS/RAF/MEK/ERK pathway develop multiple nevi. On the other hand, 50 percent of red mice with the same changes develop melanoma without being exposed to UV light. If the red mice are albino, no melanoma appears. Continue reading “Do we need pigment to develop melanoma?”
We know that dermoscopy provides us with more information than is possible with the naked eye. The trick is to understand what the additional information means, and what we should do with it! This is where research on dermoscopy and management guidelines is so important. In this case, we are particularly looking at the management of Spitz nevi. Continue reading “Management Guidelines for Dermoscopy of Spitz Nevi”
Artificial intelligence has the capacity to revolutionise skin cancer medicine, with multiple programs in development that aid in the early detection of the disease. One such program is Doctor Hazel – a platform that could someday identify cancerous moles with a success rate of 90 percent, provided it attracts enough user submissions.
Still in its infancy, Doctor Hazel was demonstrated earlier this week by a team of engineers at TechCrunch’s Disrupt San Francisco 2017 hackathon. The artificial intelligence program currently identifies cancer at an 85 percent success rate; however, the team has launched a beta and is inviting users to submit their own photos to improve the platform’s performance.
In this skin cancer update video, Associate Professor Giuseppe Argenziano shares the results of a meta-analysis of nevus-associated melanoma. The study asked whether a nevus was a precursor lesion of melanoma.
It found that only a third of melanomas arise from a pre-existing nevus, and the majority of melanomas developed from nondysplastic nevi.
If you perform skin cancer surgery in your practice, you might be interested to see the 1-minute video below with experienced skin cancer doctor Hamilton Ayres. Dr Ayres uses the principle of hydrodissection to remove a lesion on a patient’s ear. The injected fluid helps to separate the tissue planes and facilitates excision. Continue reading “How to Use the Principle of Hydrodissection in Skin Cancer Surgery”
This week we have another engaging case discussion from Dr Slavko Doslo. A 76-year-old patient presented for ROS.
What do you think of this clinical image? What is your impression? (Ignore the adjacent scar).
Skin Cancer Summit & Masterclasses
The 9th Skin Cancer Summit and Masterclasses saw international thought leaders in skin cancer medicine converge in Brisbane to collaborate with GPs from across Australia.
This week’s case discussion is about an elderly man presenting with a cough. On examination, both a basal cell carcinoma and the pigmented lesion shown here were noted.
What is your assessment? Is there anything to be concerned about? Continue reading “Case discussion: How would you treat this patient? [24 July]”